Published in Int J Oncol on August 01, 2010
Adrenocortical carcinoma. Endocr Rev (2013) 1.46
Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. J Clin Endocrinol Metab (2013) 1.20
Human adrenocortical carcinoma cell lines. Mol Cell Endocrinol (2011) 1.12
Current and emerging therapeutic options in adrenocortical cancer treatment. J Oncol (2012) 0.99
Therapy of adrenocortical cancer: present and future. Am J Cancer Res (2010) 0.96
Current and emerging therapies for advanced adrenocortical carcinoma. Oncologist (2011) 0.92
p53 Stabilization induces cell growth inhibition and affects IGF2 pathway in response to radiotherapy in adrenocortical cancer cells. PLoS One (2012) 0.75
Cell cycle dependent RRM2 may serve as proliferation marker and pharmaceutical target in adrenocortical cancer. Am J Cancer Res (2016) 0.75
Silencing of the polyamine catabolic key enzyme SSAT prevents CDK inhibitor-induced apoptosis in Caco-2 colon cancer cells. Mol Med Rep (2012) 0.75
Adrenocortical carcinoma: modern management and evolving treatment strategies. Int J Endocr Oncol (2016) 0.75
Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab (2002) 4.34
MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol (2007) 4.02
False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis (2004) 3.06
Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol (2008) 2.32
Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA. Pancreas (2006) 2.31
A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol (2008) 1.97
Alteration of local microflora and α-defensins hyper-production in colonic adenoma mucosa. J Clin Gastroenterol (2011) 1.57
Malignancies in β-thalassemia patients: first description of two cases of thyroid cancer and review of the literature. Hemoglobin (2011) 1.57
Prostate growth and inflammation. J Steroid Biochem Mol Biol (2007) 1.33
Ultrasound sensitivity for thyroid malignancy is increased by real-time elastography: a prospective multicenter study. J Clin Endocrinol Metab (2012) 1.28
Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Anticancer Res (2003) 1.27
Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke (2004) 1.22
P2X(7) purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability. Cell Immunol (2007) 1.06
Thyroid hormone receptor TRbeta1 mediates Akt activation by T3 in pancreatic beta cells. J Mol Endocrinol (2007) 1.05
The thyroid hormone T3 improves function and survival of rat pancreatic islets during in vitro culture. Islets (2010) 1.02
3,5,3'-triiodothyronine (T3) is a survival factor for pancreatic beta-cells undergoing apoptosis. J Cell Physiol (2006) 1.02
Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology (2004) 1.00
Current and emerging therapeutic options in adrenocortical cancer treatment. J Oncol (2012) 0.99
Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia: prevalence and sonographic, hormonal, and seminal characteristics. J Ultrasound Med (2012) 0.98
Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid (2004) 0.98
Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins. Clin Cancer Res (2005) 0.96
Gene polymorphisms of the renin-angiotensin-aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant. J Hypertens (2004) 0.93
3,5,3'-Triiodo-L-thyronine enhances the differentiation of a human pancreatic duct cell line (hPANC-1) towards a beta-cell-Like phenotype. J Cell Physiol (2005) 0.91
Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21. Hum Hered (2006) 0.91
Thyroid hormones induce cell proliferation and survival in ovarian granulosa cells COV434. J Cell Physiol (2009) 0.91
Atopic dermatitis and asthma. Allergy Asthma Proc (2007) 0.90
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions. Endocr Relat Cancer (2004) 0.89
Vdelta2 T-lymphocyte responses in cord blood samples from Italy and Côte d'Ivoire. Immunology (2008) 0.89
Thyroid hormone T3 counteracts STZ induced diabetes in mouse. PLoS One (2011) 0.88
Interleukin 12B (IL12B) genetic variation and pulmonary tuberculosis: a study of cohorts from The Gambia, Guinea-Bissau, United States and Argentina. PLoS One (2011) 0.88
Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells. Int J Radiat Biol (2011) 0.87
Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies. Eur J Endocrinol (2009) 0.87
Fractionated ionizing radiation exposure induces apoptosis through caspase-3 activation and reactive oxygen species generation. Anticancer Res (2007) 0.86
Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment. J Clin Endocrinol Metab (2012) 0.86
Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells. Exp Cell Res (2011) 0.86
T(3) preserves ovarian granulosa cells from chemotherapy-induced apoptosis. J Endocrinol (2012) 0.86
Multiplex ligation-dependent probe amplification (MLPA) assay for the detection of CYP21A2 gene deletions/duplications in congenital adrenal hyperplasia: first technical report. Clin Chim Acta (2009) 0.86
Central serous chorioretinopathy as a presenting symptom of endogenous Cushing syndrome: a case report. Eur J Ophthalmol (2011) 0.85
In vitro restoration of functional SMN protein in human trophoblast cells affected by spinal muscular atrophy by small fragment homologous replacement. Hum Gene Ther (2005) 0.84
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes. J Exp Clin Cancer Res (2013) 0.83
Oxidation of hypotaurine and cysteine sulphinic acid by peroxynitrite. Biochem J (2005) 0.83
Gemcitabine treatment of experimental C6 glioma: the effects on cell cycle and apoptotic rate. Anticancer Res (2006) 0.83
The TRbeta1 is essential in mediating T3 action on Akt pathway in human pancreatic insulinoma cells. J Cell Biochem (2009) 0.82
A combined synthetic-fibrin scaffold supports growth and cardiomyogenic commitment of human placental derived stem cells. PLoS One (2012) 0.82
Soy protein formulas in children: no hormonal effects in long-term feeding. J Pediatr Endocrinol Metab (2004) 0.81
Is DD3 a new prostate-specific gene? Anticancer Res (2003) 0.80
E-cadherin and alpha-catenin expression in normal, hyperplastic and neoplastic endometrium. Anticancer Res (2010) 0.79
A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form. BMC Med Genet (2009) 0.79
Comparison of chromogranin A, insulin-like growth factor 1 and prostate-specific antigen serum markers in prostate adenocarcinoma and benign prostatic hyperplasia. Urol Int (2008) 0.79
Thyroid hormones (T3 and T4): dual effect on human cancer cell proliferation. Anticancer Res (2011) 0.78